The Group Room at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium

C. Kent Osborne, MD: Breast Cancer Treatment – A Year In Review

Jose Baselga, MD, PhD: BOLERO-2 Findings Confirm Efficacy of Everolimus Plus Exemestane

Jose Baselga, MD, PhD: CLEOPATRA Pertuzumab Trial Increases Progression-Free Survival

Eric P. Winer, MD: Endocrine Therapy For Breast Cancer – Looking Into the Future

Eric P. Winer, MD: Medical Economics – The Cost of Care

Robert A. Hiatt, MD, PhD: Institute of Medicine Report (IOM) – Breast Cancer & the Environment

Julie R. Gralow, MD: SWOG SO226 Trial and Bisphosphonates Update

Clifford A. Hudis, MD: What’s New With Chemotherapy Trials?

Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS)

Martine Piccart, MD, PhD: Her Goals As the Current President Of ESMO

Prof. Michael Baumann: Overview of the 2011 European Multidisciplinary Cancer Congress in Stockholm

Prof. Vincenzo Valentini, MD: An Overview of EMCC 2011 in Stockholm from the President of ESTRO

Keith Kerr, MD: Biomarkers and Personalized Medicine in Lung Cancer

Prof. Thierry Le Chevalier, MD: Management of Early Stage Non-Small Cell Lung Cancer

Prof. Michael Marberger, MD: Advances in Advanced Prostate Cancer from EMCC 2011

Prof. Per-Anders Abrahamsson, MD: Prostate Cancer Highlights from EMCC 2011

Prof. Per-Anders Ambrahamsson, MD: What European Men Need to Know About Prostate Cancer

Prof. Bernard Escudier, MD: Advancements in Kidney Cancer

Prof. Hans-Joachim Schmoll, MD: Colorectal Cancer Highlights from EMCC 2011

Advocacy in Action: Metastatic Breast Cancer

Living With Metastatic Breast Cancer: Shirley Mertz

Living With Metastatic Breast Cancer: Maria Wetzel

What Does the Word Survivor Really Mean for the Metastatic Breast Cancer Patient?

The Need For More Metastatic Breast Cancer Specific Clinical Trials

How to Encourage More Tissue Collection for Metastatic Breast Cancer Research

The Need For Evidence Based Treatment Guidelines for Metastatic Breast Cancer

Looking at Subpopulations In Metastatic Breast Cancer

Access to Care for Metastatic Breast Cancer Patients

The Importance of Doctor Communication for the Metastatic Breast Cancer Patient